<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01456754</url>
  </required_header>
  <id_info>
    <org_study_id>MEC 10-3-057</org_study_id>
    <nct_id>NCT01456754</nct_id>
  </id_info>
  <brief_title>Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning in Impaired Glucose Tolerant (IGT) Men</brief_title>
  <official_title>Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning in Impaired Glucose Tolerant (IGT) Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nederlandse Zuivel Organisatie</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of feeding frequency on glucose and
      insulin metabolism and substrate partitioning in impaired glucose tolerant (IGT) men.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose metabolism</measure>
    <time_frame>24 hour profile</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin metabolism</measure>
    <time_frame>24 hour profile</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in substrate partitioning (fat, carbohydrate and protein oxidation) between the two intervention diets</measure>
    <time_frame>24 hour profiles</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic markers (FFA and TG metabolism)</measure>
    <time_frame>24 hour profile</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Glucose Intolerance</condition>
  <arm_group>
    <arm_group_label>High feeding frequency (14x)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>low feeding frequency (3x)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>low feeding frequency (3x)</intervention_name>
    <description>3 meals a day</description>
    <arm_group_label>low feeding frequency (3x)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High feeding frequency (14x)</intervention_name>
    <description>14 meals a day</description>
    <arm_group_label>High feeding frequency (14x)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI: 20-35 kg/m2

          -  Gender: Male

          -  Age: subjects has to be older than 18 and younger than 70 years old

          -  Impaired Glucose Tolerant (IGT) = plasma glucose, two hours after consuming 75g
             glucose, appears to be superior to 7.8mmol/l (normal level) but remains inferior to
             11.1mmol/l (diabetes level) and fasting plasma glucose is less than 7.0mmol/l.

          -  Caucasian

        Exclusion Criteria:

          1. Lactose intolerant

          2. Diabetes Mellitus

          3. Cardiovascular diseases

          4. Stomach and intestinal diseases

          5. Normal glucose levels after 2 hours

          6. Anticoagulants

          7. Medication that has a effect on energy and glucose homeostasis and absorption of foods

          8. Conditions or situations when subjects can't lose 500 ml blood
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wim Saris, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Maastricht</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2011</study_first_submitted>
  <study_first_submitted_qc>October 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2011</study_first_posted>
  <last_update_submitted>December 14, 2011</last_update_submitted>
  <last_update_submitted_qc>December 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 15, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Insulin Metabolism</keyword>
  <keyword>Glucose Metabolism</keyword>
  <keyword>Substrate Partitioning</keyword>
  <keyword>Muscle Biopsies</keyword>
  <keyword>Feeding Frequency</keyword>
  <keyword>Insulin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

